Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Patients With Relapsed or Refractory Advanced Non-small Cell Lung Carcinoma

NCT00101413 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00101413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00101413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multicenter Uncontrolled Trial of BAY43-9006 in Patients With Relapsed or Refractory Advanced Non-small Cell Lung Carcinoma
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
April 30, 2008
Enrollment
52 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, carcinoma, non-small cell lung